Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01063348 · ClinicalTrials.gov registry record · Phase 2
N-Acetyl Cysteine in Pathologic Skin Picking
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT01063348 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 66 participants.
The verdict
NCT01063348, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The goal of the proposed study is to evaluate the comparative efficacy of N-acetyl cysteine to placebo in pathologic skin picking. Thirty subjects with pathologic skin picking will receive 12 weeks of double-blind treatment with N-acetyl cysteine or matching placebo. The hypothesis to be tested is that N-acetyl cysteine will be more effective than placebo in patients with pathologic skin picking. The proposed study will provide needed data on the treatment of an often disabling disorder that currently lacks a clearly effective treatment.
Interventions
- DRUG Placebo
- DRUG N-Acetyl Cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01063348
The ClinicalTrials.gov registry entry for NCT01063348 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01063348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01063348 about?
NCT01063348 is a clinical study titled "N-Acetyl Cysteine in Pathologic Skin Picking". The goal of the proposed study is to evaluate the comparative efficacy of N-acetyl cysteine to placebo in pathologic skin picking. Thirty subjects with pathologic skin picking will receive 12 weeks of double-blind treatment with N-acetyl cysteine or matching placebo. The hypothesis to be tested is t...
What is the current status of trial NCT01063348?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2012-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01063348?
The interventions under investigation include: Placebo (DRUG), N-Acetyl Cysteine (DRUG).
Who is sponsoring clinical trial NCT01063348?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.